Physician profile
John D Stanley
NPI 1447244348
$1,044.71
in general payments reported to CMS, 2019-2025
11 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $69.46 · 2021: $17.49 · 2022: $270 · 2023: $117 · 2024: $288 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $267.42 | 2022-2025 | Grafix Pl, Oasis, Grafix Xc |
| Tela Bio, INC. | $161.46 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $159.69 | 2022 | |
| Axonics, INC. | $99.49 | 2024 | Bulkamid, Axonics |
| Hologic Sales and Service, LLC | $88.97 | 2025 | Coolseal Generator |
| Smoky Mountain Surgical LLC | $88.62 | 2024 | |
| Intuitive Surgical, INC. | $69.46 | 2020 | |
| Silk Road Medical, INC. | $57.31 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Olympus America INC. | $17.54 | 2023 | Endoclot Phs, Endoclot Sis |
| Takeda Pharmaceuticals U.S.A., INC. | $17.49 | 2021 | |
| Haemonetics Corporation | $17.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.